CoLucid Pharmaceuticals, Inc Employee Directory

Biotechnology ResearchMassachusetts, United States2-10 Employees

CoLucid Pharmaceuticals, Inc. is a biotechnology research company focused on developing therapies for migraine and related headache disorders. Its portfolio centers on lasmiditan, an orally administered drug for acute treatment and an intravenously delivered form for clinical use by health care professionals, targeting the 5-HT1F receptor pathway in the trigeminal nerve. The company emphasizes a novel approach designed to deliver efficacy without vasoconstriction, aiming to address migraines in patient populations with cardiovascular risk or stable cardiovascular disease, which broadens potential treatment options for these patients. Based in Cambridge, Massachusetts, CoLucid was founded in 2005 and has pursued a development program that includes a Phase 3 trial aligned with the FDA under a Special Protocol Assessment, reflecting its focus on advancing migraine therapy through rigorous clinical evaluation.

Sign up for free to view info

Company overview Email format